Announcements Trials

Browse Landscape

Sponsor

Conditions

Prostatic Neoplasms 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Metastatic Hormone-sensitive Prostate Cancer 2 Non-metastatic, Hormone naïve Prostate Cancer 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hormone Sensitive Prostate Cancer 1 Adenocarcinoma of the Prostate 1

Interventions

pembrolizumab 37 Paclitaxel 36 Carboplatin 31 Cyclophosphamide 22 Albumin-Bound Paclitaxel 20 atezolizumab 16 130-nm albumin-bound paclitaxel 16 Taxes 15 Doxorubicin 15 Cisplatin 13 Capecitabine 13 Nivolumab 10 Docetaxel 8 olaparib 7 Gemcitabine 6 Everolimus 6 talazoparib 5 durvalumab 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Bevacizumab 5 veliparib 4 spartalizumab 4 sacituzumab govitecan 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Specimen Handling 4 Immunoglobulin G 4 trilaciclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × Androgen Antagonists × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡